focus -WSS

focus

author：fashion 2025-10-02 23:31:01 - browse：8

PHILADELPHIA — Novo Nordisk, which has dominated the diabetes and obesity markets with its blockbuster drugs Ozempic and Wegovy, now also wants to be a major player in heart disease.

The landmark Select trial presented over the weekend — which showed Wegovy significantly cut the risk of heart complications — is just one of many efforts by the Danish drugmaker to expand into the cardiovascular space. It’s also developing several treatments specific to heart disease and is acquiring a medication for high blood pressure.

“We have a clear vision of being an established cardiovascular company, just as we see ourselves as leaders in diabetes and obesity,” Martin Lange, Novo’s executive vice president of development, said in an interview here at the American Heart Association conference.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Moonlake's readout produced a cash windfall. Risks remain
Next article： Creating egg and sperm cells from stem cells raises ethical issues

WSS

July 4th fireworks can be stressful for dogs. These 6 tips can keep them calm and safe

Physicians and social media: If you see something, say something?

Ukraine holds disaster drills amid fears Russia could sabotage nuclear power plant

10 states plan to sue EPA over standards for residential wood

App could help diagnose ear infections more accurately — and at home

5 to watch: Tech startups trying to solve health care's staffing crisis

hotspot

focus

knowledge

Medical records are filled with copy

Some in Scotland's Orkney Islands want to return to Norway after 550 years

State Dept. review finds Biden bears some blame for Afghanistan failures

Masked assailants attack a journalist and a lawyer in Russia's Chechnya province

How to save PrEP access — and even expand it

Russians and Belarusians back at Wimbledon as war in Ukraine continues

Peter Hotez and the public health issue of online harassment

Colonoscopy prep: Liquid

Virginia high school admissions case could be legal follow

Some in Scotland's Orkney Islands want to return to Norway after 550 years

focus

U.K. researchers warn about biases in medical devices, algorithms

Plastic surgeons increase patient psychiatric screenings

Physicians and social media: If you see something, say something?

Russians and Belarusians back at Wimbledon as war in Ukraine continues

Brazil's Neymar fined $3.3 million for illegal artificial lake at mansion outside Rio

Elon Musk announces 'temporary limits' for reading Twitter posts

entertainment

entertainment

focus

focus